DIFFUSION PHARMACEUTICALS IN's ticker is DFFN and the CUSIP is 253748206. A total of 14 filers reported holding DIFFUSION PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $4,000 | -20.0% | 10,000 | 0.0% | 0.00% | – |
Q2 2018 | $5,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
Q1 2018 | $5,000 | +150.0% | 10,000 | +566.7% | 0.00% | – |
Q3 2017 | $2,000 | -33.3% | 1,500 | 0.0% | 0.00% | – |
Q2 2017 | $3,000 | -50.0% | 1,500 | 0.0% | 0.00% | – |
Q1 2017 | $6,000 | +100.0% | 1,500 | 0.0% | 0.00% | – |
Q4 2016 | $3,000 | – | 1,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Swift Run Capital | 2,508,017 | $1,369,000 | 0.98% |
WHITTIER TRUST CO OF NEVADA INC | 135,551 | $73,000 | 0.01% |
Virtu Financial LLC | 25,335 | $14,000 | 0.00% |
Signature Financial Management, Inc. | 12,350 | $7,000 | 0.00% |
IHT Wealth Management, LLC | 3,800 | $2,000 | 0.00% |
NORTHERN TRUST CORP | 30,458 | $17,000 | 0.00% |
St. Johns Investment Management Company, LLC | 23 | $0 | 0.00% |
UBS Group AG | 28,496 | $16,000 | 0.00% |
Advisor Group, Inc. | 4,370 | $2,000 | 0.00% |
CIBC Private Wealth Group LLC | 500 | $0 | 0.00% |